GMP Cell Therapy Consumables Market Size is valued at USD 22.72 Bn in 2024 and is predicted to reach USD 312.91 Bn by the year 2034 at a 30.1% CAGR during the forecast period for 2025-2034.
Good Manufacturing Practices (GMP) ensure that products are manufactured and maintained under good quality standards. Cell therapy development processes are complex and require good pharmaceutical systems and quality control (QC).
The market growth is attributed to rising drug discovery, the high prevalence of cancer, cell therapy innovations, and the surging use of cell therapy & GMP cell therapy consumables. However, stringent regulatory policies may hamper the market growth. The increasing collaborations & partnership activities within companies operating in the GMP cell therapy consumables market for developing new products and cell therapy treatments also support the market growth. For instance, in March 2022, FUJIFILM Irvine Scientific, Inc. acquired Shenandoah Biotechnology, Inc., a leading manufacturer of recombinant proteins. Shenandoah Biotechnology recently launched their CTG Grade line of cytokines & growth factors manufactured according to cGMP guidelines in the company's new state-of-the-art, ISO 9001:2015 certified facility.
Moreover, the last five years have been a rebirth for cell therapy and gene therapy (CGT) innovation, and the COVID-19 pandemic has accelerated these developments.
The GMP Cell Therapy Consumables Market is segmented into Product, cell therapy, Process, and end user. By Product, the market is categorized into kits, reagents/molecular biology reagents, growth factors/cytokines and interleukins, and others. The cell therapy segment comprises NK cell therapy, stem cell therapy, T-cell therapy, and others. By Process, the market is divided into cell collection and characterization/sorting and separation, cryopreservationcell culture and expansion/preparation, cell processing and formulation, cell distribution/handling, cell isolation and activation, process monitoring and control/readministration/quality assurance, and others. The end user segment consists of clinical, commercial, and research.
The kits segment held the largest GMP cell therapy consumables market share in 2022. However, the growth factors/cytokines and interleukins segment is predicted to capture the highest CAGR over the forecast period.
In 2022, the T-cell therapy segment held the largest share of the GMP cell therapy consumables market. Various clinical trials on Chimeric antigen receptor (CAR) T-cell therapy are being conducted for cancer treatment. The therapy improves the immune system's power, protecting against infections by destroying harmful viruses & bacteria. Such increasing clinical trials of CAR T-cell therapy are surging the demand for GMP cell therapy consumables.
The cell collection, characterization/sorting, and separation segment are expected to drive the market during the forecast period. Moreover, the cryopreservation segment is anticipated to grow fastest in the coming years. Several companies in this market are building the GMP-compliant cell sorter to reduce contamination.
In 2022, the clinical segment led the GMP cell therapy consumables market. Increasing clinical trials due to the high prevalence of chronic diseases, rising clinical studies and research efforts for developing new cell therapies are expected to enhance the market growth over the projected period.
Factors such as the increasing demand for cell therapies, the surging use of GMP cell therapy consumables, and rising research efforts in drug discoveries are responsible for the blooming of the GMP Cell Therapy Consumables Market in North America. At the same time, the Asia Pacific regional market is predicted to register the swiftest growth in the upcoming years. Growing cancer cases, chronic diseases, autoimmune disorders, and infectious diseases, increasing adoption of GMP cell therapy consumable products in India, and the development of cell therapy products are among the factors supporting the growth of the GMP Cell Therapy Consumables Market in this region.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 22.72 Bn |
|
Revenue Forecast In 2034 |
USD 312.91 Bn |
|
Growth Rate CAGR |
CAGR of 30.1% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product, By Cell Therapy, By Process, By End User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; South East Asia |
|
Competitive Landscape |
Sartorius AG, Thermo Fisher Scientific Inc., Miltenyi Biotec BV & Co KG, Bio-Techne Corp, Corning Inc., FUJIFILM Irvine Scientific Inc., Lonza Group AG, BPS Bioscience Inc., Merck KGaA, Global Life Sciences Solutions USA LLC., and Others |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global GMP Cell Therapy Consumables Market Snapshot
Chapter 4. Global GMP Cell Therapy Consumables Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Metaverse Industry
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact on Metaverse Industry
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. By Product & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Product:
5.2.1. Kits
5.2.2. Reagents/Molecular Biology Reagents
5.2.3. Growth Factors/Cytokines and Interleukins
5.2.4. Others
Chapter 6. Market Segmentation 2: By Cell Therapy Estimates & Trend Analysis
6.1. By Product & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Cell Therapy:
6.2.1. NK Cell Therapy
6.2.2. Stem Cell Therapy
6.2.3. T-Cell Therapy
6.2.4. Others
Chapter 7. Market Segmentation 3: By Process Estimates & Trend Analysis
7.1. By Product & Market Share, 2024-2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Process:
7.2.1. Cell Collection and Characterization/Sorting and Separation
7.2.2. Cell Culture and Expansion/Preparation
7.2.3. Cryopreservation
7.2.4. Cell Processing and Formulation
7.2.5. Cell Isolation and Activation
7.2.6. Cell Distribution/Handling
7.2.7. Others
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. By Product & Market Share, 2024-2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End User:
8.2.1. Clinical
8.2.2. Commercial
8.2.3. Research
Chapter 9. GMP Cell Therapy Consumables Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By Product, 2021-2034
9.1.2. North America GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By Cell Therapy, 2024-203
9.1.3. North America GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By Process, 2021-2034
9.1.4. North America GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By, End User 2021-2034
9.1.5. North America GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.1.5.1. U.S.
9.1.5.2. Canada
9.2. Europe
9.2.1. Europe GMP Cell Therapy Consumables Market revenue (US$ Million) by By Product, 2021-2034
9.2.2. Europe GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By Cell Therapy, 2021-2034
9.2.3. Europe GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By Process 2021-2034
9.2.4. Europe GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By End User,2021-2034
9.2.5. Europe GMP Cell Therapy Consumables Market revenue (US$ Million) by country, 2024-2034
9.2.5.1. Germany
9.2.5.2. Poland
9.2.5.3. France
9.2.5.4. Italy
9.2.5.5. Spain
9.2.5.6. UK
9.2.5.7. Rest of Europe
9.3. Asia Pacific
9.3.1. Asia Pacific GMP Cell Therapy Consumables Market revenue (US$ Million) by By Product, 2021-2034
9.3.2. Asia Pacific GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By Cell Therapy, 2021-2034
9.3.3. Asia Pacific GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By Process, 2021-2034
9.3.4. Asia Pacific GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By End User, 2024-20
9.3.5. Asia Pacific GMP Cell Therapy Consumables Market revenue (US$ Million) by country, 2021-2034
9.3.5.1. China
9.3.5.2. India
9.3.5.3. Japan
9.3.5.4. Australia
9.3.5.5. Rest of Asia Pacific
9.4. Latin America
9.4.1. Latin America GMP Cell Therapy Consumables Market revenue (US$ Million) by By Product, 2021-2034
9.4.2. Latin America GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By Cell Therapy, 2021-2034
9.4.3. Latin America GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By Process, 2021-2034
9.4.4. Latin America GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
9.4.5. Latin America GMP Cell Therapy Consumables Market revenue (US$ Million) by country, (US$ Million) 2021-2034
9.4.5.1. Brazil
9.4.5.2. Rest of Latin America
9.5. Middle East & Africa
9.5.1. Middle East & Africa GMP Cell Therapy Consumables Market revenue (US$ Million) by By Product, 2021-2034
9.5.2. Middle East & Africa GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By Cell Therapy, 2021-2034
9.5.3. Middle East & Africa GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By Process, 2021-2034
9.5.4. Middle East & Africa GMP Cell Therapy Consumables Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
9.5.5. Middle East & Africa GMP Cell Therapy Consumables Market revenue (US$ Million) by country, (US$ Million) 2021-2034
9.5.5.1. South Africa
9.5.5.2. GCC Countries
9.5.5.3. Rest of MEA
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Sartorius AG
10.2.2. Thermo Fisher Scientific Inc
10.2.3. Miltenyi Biotec BV & Co KG
10.2.4. Bio-Techne Corp
10.2.5. Corning Inc
10.2.6. FUJIFILM Irvine Scientific Inc
10.2.7. Lonza Group AG
10.2.8. BPS Bioscience Inc
10.2.9. Merck KGaA
10.2.10. Global Life Sciences Solutions USA LLC
10.2.11. Other Prominent Players
GMP Cell Therapy Consumables Market By Product-
GMP Cell Therapy Consumables Market By Cell Therapy-
GMP Cell Therapy Consumables Market By Process-
GMP Cell Therapy Consumables Market By End User-
GMP Cell Therapy Consumables Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
